Answers are grounded in this paper and cite their sources.
Review explores how correlative analysis impacts product quality in cell and gene therapy, indicating its significance in development.
Correlative analysis is widely used in drug product development and manufacturing to explore the potential associations between attributes of interest. The manufacturing and control of cell and gene therapy (CGT) products are often affected by multiple factors, such as limited knowledge of product characteristics, variable starting materials, complex manufacturing and limited manufacturing experience. Understanding of correlations among process, product and clinical outcome parameters can support process optimization and improve product quality. In this paper, we review the applications of correlative analysis and discuss their implications in CGT product development and manufacturing. We also discuss the unique challenges associated with performing correlative analysis in CGT. Finally, we provide a summary of statistical techniques commonly used to identify associations among attributes related to Chemistry, Manufacturing and Controls (CMC) and clinical outcome. This review aims to provide insights into the effective use of correlative analysis to enhance the development and manufacturing of CGT products.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: